What is Schrodinger, Inc. (SDGR) stock price today?

Schrodinger, Inc. (SDGR) is currently trading at $26.39, down 3.3% today.

What is SDGR P/E ratio?

Schrodinger, Inc.'s P/E ratio is -40.96. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is SDGR return on equity (ROE)?

Schrodinger, Inc.'s return on equity (ROE) is -16.37%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is Schrodinger, Inc.'s market cap?

Schrodinger, Inc. has a market capitalization of $1.97B.

NASDAQ · Medical - Healthcare Information Services

Schrodinger, Inc. (SDGR) Stock

$26.39 -3.30% NASDAQ: SDGR Healthcare

Valuation

Metric	Value
Price	$26.39
Market Cap	$1.97B
P/E Ratio	-40.96
P/B Ratio	6.88
P/S Ratio	8.74
EPS (TTM)	$-1.41
52-Week High	$32.60
52-Week Low	$10.95
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-16.37%
ROA	-8.48%
ROCE	-32.89%
Gross Margin	-65.23%
Operating Margin	-65.23%
Net Margin	-20.98%
Debt/Equity	0.33
Current Ratio	2.75

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$138.0M	$181.0M	$217.0M	$208.0M	$256.0M
Operating Profit	$-111.0M	$-147.0M	$-177.0M	$-209.0M	$-167.0M
Net Profit	$-100.0M	$-149.0M	$41.0M	$-187.0M	$-103.0M
EPS	$-1.43	$-2.10	$0.54	$-2.57	$-1.41
Op Margin	-80.8%	-81.1%	-81.9%	-100.8%	-65.2%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$756.0M	$689.0M	$803.0M	$823.0M	$726.0M
Total Liabilities	$199.0M	$241.0M	$254.0M	$402.0M	$362.0M
Cash	$120.0M	$90.0M	$155.0M	$147.0M	$231.0M
Borrowings	$80.0M	$116.0M	$128.0M	$118.0M	$109.0M

Latest News

Schrödinger to Announce Second Quarter 2026 Financial Results on August 5 Business Wire · Jul 22, 2026 Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Business Wire · Jul 20, 2026 AMD Is Up 150% This Year But Here Are 5 Overlooked Stocks Betting on What Comes Next 24/7 Wall St. · Jul 1, 2026 AI Is Transforming Drug Discovery. Here Is the Next Trillion-Dollar Biotech Opportunity 24/7 Wall St. · Jun 30, 2026 Strength Seen in Senseonics (SENS): Can Its 6.1% Jump Turn into More Strength? Zacks · Jun 29, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-71.0M	$-120.0M	$-137.0M	$-157.0M	$14.0M
Investing Cash Flow	$-24.0M	$82.0M	$180.0M	$142.0M	$56.0M
Financing Cash Flow	$8.0M	$2.0M	$9.0M	$1.0M	$0
Net Cash Flow	$-80.0M	$-28.0M	$65.0M	$2.0M	$75.0M
Free Cash Flow	$-78.0M	$-128.0M	$-150.0M	$-165.0M	$12.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	-0.35
EV / EBITDA	-45.45
FCF Yield	-1.43%
Quick Ratio	2.71
Interest Coverage	0.00
Return 1Y	-34.30%
Return 3Y	-69.49%
Return 5Y	-76.09%

Ownership

Insiders Held3.01%

Institutions Held98.22%

Institutions Float Held101.27%

Institutional Holder	Shares	Report Date
Blackrock Inc.	9,678,560	2026-03-31
Gates Foundation Trust	6,981,664	2026-03-31
Rubric Capital Management LP	6,000,000	2026-03-31
Vanguard Portfolio Management LLC	3,862,197	2026-03-31
Sumitomo Mitsui Trust Group, Inc.	3,190,837	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ABCLAbCellera Biologics Inc.	$12.02	-6.31%	-21.26	$3.67B	0.00%
CERTCertara, Inc.	$8.64	-3.57%	-21.11	$1.34B	0.00%
GENBGenerate Biomedicines, Inc.	$13.99	+3.10%	-13.20	$1.79B	0.00%
HYFTMindWalk Holdings Corp.	$1.43	-4.67%	-5.23	$67.19M	0.00%
LTRNLantern Pharma Inc.	$0.83	-8.79%	-0.51	$10.59M	0.00%

About Schrodinger, Inc.

Schrodinger, Inc. is led by CEO Ramy Farid, employs 891 people, headquartered in US, publicly traded since 2020.

Schrodinger, Inc. (SDGR) stock trades at $26.39 with a market capitalization of $1.97B. The stock is valued at a price-to-earnings (P/E) ratio of -40.96, price-to-book of 6.88, price-to-sales of 8.74. Over the past 52 weeks the stock has ranged between $10.95 and $32.60, and currently trades 19.0% below its 52-week high.

On profitability, Schrodinger, Inc. generates a return on equity (ROE) of -16.37%, return on capital employed of -32.89%, an operating margin of -65.23%, a net profit margin of -20.98%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1169.93 -1.58% JNJ Johnson & Johnson $256.48 -0.76% ABBV AbbVie Inc. $272.42 +0.39% MRK Merck & Company, Inc. Common Stock (new) $142.40 -0.28% UNH UnitedHealth Group Incorporated Common Stock (DE) $370.95 -1.34% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $651.98 -1.52% AMGN Amgen Inc. $407.44 -1.37% GILD Gilead Sciences, Inc. $147.10 +0.17% ABT Abbott Laboratories $98.49 -0.24% NVO Novo Nordisk A/S $38.18 -0.21%

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides